GPO and PBM: Can They Create a Common Formulary?
Executive SummaryThe Holy Grail of pharmacy management has always been to link inpatient and outpatient formularies so patients started on one drug during their hospital stays aren't forced to switch to another for their at-home therapies. Given the fragmentation of the provider industry, however, few drug companies took the effort seriously.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.